PDF herunterladen
CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2017; 04(04): S49-S55
DOI: 10.4103/jnacc-jnacc-75.16
Conference Proceeding
Thieme Medical and Scientific Publishers Private Ltd.

Critical care of subarachnoid haemorrhage

Michael J. Souter
1   Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Harborview Medical Center, Seattle, WA, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
08. Mai 2018 (online)

   Lizenzen und Reprints

Abstract

Subarachnoid haemorrhage (SAH) is a consistent presentation of haemorrhagic stroke of significance to clinicians in neurocritical care, inducing consequent effects on non-neurological systems, while at the same time, rendering the brain vulnerable to secondary physiological insult modifying neurological outcome, despite control of the original point of haemorrhage. Coordinated treatment depends on comprehensive evaluation of both cerebral and systemic physiology, identifying and treating impaired function. The presence of a dedicated neurocritical care team can benefit outcome. Protocols of care have evolved to meet evidence-based challenges, discarding potentially deleterious components of hypervolaemia and haemodilution, while maintaining pressure-guided perfusion. Treatment targets have also evolved with a shift in focus away from SAH-associated vasospasm, towards actual ischaemic outcome – illustrated by lack of effectiveness of pharmaceutical treatments of vasospasm. Clinicians must consequently review pathophysiological mechanisms of injury and devise new treatment opportunities.

Keywords

Brain - critical care - secondary insult - subarachnoid haemorrhage
 

  • REFERENCES

  • 1 Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 1998; 50: 1413-8
    CrossrefPubMedGoogle Scholar
  • 2 Connolly Jr. ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT. et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012; 43: 1711-37
    CrossrefPubMedGoogle Scholar
  • 3 Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol 2009; 8: 355-69
    CrossrefPubMedGoogle Scholar
  • 4 Ingall T, Asplund K, Mähönen M, Bonita R. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 2000; 31: 1054-61
    CrossrefPubMedGoogle Scholar
  • 5 Pobereskin LH. Incidence and outcome of subarachnoid haemorrhage: A retrospective population based study. J Neurol Neurosurg Psychiatry 2001; 70: 340-3
    CrossrefPubMedGoogle Scholar
  • 6 Schievink WI. Intracranial aneurysms. N Engl J Med 1997; 336: 28-40
    CrossrefPubMedGoogle Scholar
  • 7 Sforza DM, Putman CM, Cebral JR. Hemodynamics of cerebral aneurysms. Annu Rev Fluid Mech 2009; 41: 91-107
    CrossrefPubMedGoogle Scholar
  • 8 Linn FH, Wijdicks EF, van der Graaf Y, Weerdesteyn-van Vliet FA, Bartelds AI, van Gijn J. Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. Lancet 1994; 344: 590-3
    CrossrefPubMedGoogle Scholar
  • 9 Morgenstern LB, Luna-Gonzales H, Huber Jr. JC, Wong SS, Uthman MO, Gurian JH. et al. Worst headache and subarachnoid hemorrhage: Prospective, modern computed tomography and spinal fluid analysis. Ann Emerg Med 1998; 32 (3 Pt 1) 297-304
    PubMedGoogle Scholar
  • 10 Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. N Engl J Med 2000; 342: 29-36
    CrossrefPubMedGoogle Scholar
  • 11 Perry JJ, Sivilotti ML, Stiell IG, Wells GA, Raymond J, Mortensen M. et al. Should spectrophotometry be used to identify xanthochromia in the cerebrospinal fluid of alert patients suspected of having subarachnoid hemorrhage?. Stroke 2006; 37: 2467-72
    CrossrefPubMedGoogle Scholar
  • 12 U-King-Im JM, Koo B, Trivedi RA, Higgins NJ, Tay KY, Cross JJ. et al. Current diagnostic approaches to subarachnoid haemorrhage. Eur Radiol 2005; 15: 1135-47
    CrossrefPubMedGoogle Scholar
  • 13 Kumar A, Kato Y, Hayakawa M, Junpei O, Watabe T, Imizu S. et al. Recent advances in diagnostic approaches for sub-arachnoid hemorrhage. Asian J Neurosurg 2011; 6: 94-8
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 14 Urbach H, Zentner J, Solymosi L. The need for repeat angiography in subarachnoid haemorrhage. Neuroradiology 1998; 40: 6-10
    CrossrefPubMedGoogle Scholar
  • 15 Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28: 14-20
    CrossrefPubMedGoogle Scholar
  • 16 Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 1988; 68: 985-6
    PubMedGoogle Scholar
  • 17 Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6: 1-9
    CrossrefPubMedGoogle Scholar
  • 18 van Heuven AW, Dorhout Mees SM, Algra A, Rinkel GJ. Validation of a prognostic subarachnoid hemorrhage grading scale derived directly from the Glasgow Coma Scale. Stroke 2008; 39: 1347-8
    CrossrefPubMedGoogle Scholar
  • 19 Starke RM, Connolly Jr. ES. Participants in the international multi-disciplinary consensus conference on the critical care management of subarachnoid haemorrhage. Rebleeding after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011; 15: 241-6
    CrossrefPubMedGoogle Scholar
  • 20 van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: Diagnosis, causes and management. Brain 2001; 124 (Pt 2) 249-78
    CrossrefPubMedGoogle Scholar
  • 21 Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: A literature review. World Neurosurg 2013; 79: 307-12
    CrossrefPubMedGoogle Scholar
  • 22 Fridriksson S, Säveland H, Jakobsson KE, Edner G, Zygmunt S, Brandt L. et al. Intraoperative complications in aneurysm surgery: A prospective national study. J Neurosurg 2002; 96: 515-22
    CrossrefPubMedGoogle Scholar
  • 23 Pinna G, Pasqualin A, Vivenza C, Da Pian R. Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: A retrospective clinical study. Acta Neurochir (Wien) 1988; 93: 77-87
    CrossrefPubMedGoogle Scholar
  • 24 Harrigan MR, Rajneesh KF, Ardelt AA, Fisher 3rd WS. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: Effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Neurosurgery 2010; 67: 935-9
    CrossrefPubMedGoogle Scholar
  • 25 Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med 2006; 354: 387-96
    CrossrefPubMedGoogle Scholar
  • 26 Wijdicks EF, Vermeulen M, Murray GD, Hijdra A, van Gijn J. The effects of treating hypertension following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 1990; 92: 111-7
    CrossrefPubMedGoogle Scholar
  • 27 van Gijn J, Hijdra A, Wijdicks EF, Vermeulen M, van Crevel H. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg 1985; 63: 355-62
    CrossrefPubMedGoogle Scholar
  • 28 Dorai Z, Hynan LS, Kopitnik TA, Samson D. Factors related to hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52: 763-9
    CrossrefPubMedGoogle Scholar
  • 29 Ochiai H, Yamakawa Y. Continuous lumbar drainage for the preoperative management of patients with aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 2001; 41: 576-80
    CrossrefPubMedGoogle Scholar
  • 30 Dorsch NW, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effects. J Clin Neurosci 1994; 1: 19-26
    CrossrefPubMedGoogle Scholar
  • 31 Dorsch N. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. Acta Neurochir Suppl 2011; 110 (Pt 1) 5-6
    PubMedGoogle Scholar
  • 32 Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A. et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: A randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 2011; 10: 618-25
    CrossrefPubMedGoogle Scholar
  • 33 Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. J Cereb Blood Flow Metab 2011; 31: 1443-51
    CrossrefPubMedGoogle Scholar
  • 34 Etminan N, Vergouwen MD, Macdonald RL. Angiographic vasospasm versus cerebral infarction as outcome measures after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 2013; 115: 33-40
    PubMedGoogle Scholar
  • 35 Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D. et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: The Fisher scale revisited. Stroke 2001; 32: 2012-20
    CrossrefPubMedGoogle Scholar
  • 36 Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien) 1989; 100: 12-24
    CrossrefPubMedGoogle Scholar
  • 37 Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003; 98: 978-84
    CrossrefPubMedGoogle Scholar
  • 38 Feigin VL, Rinkel GJ, Algra A, van Gijn J. Circulatory volume expansion for aneurysmal subarachnoid hemorrhage. Cochrane Database Syst Rev 2000; 2 DOI: CD000483.
    CrossrefPubMedGoogle Scholar
  • 39 Lee KH, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care 2006; 4: 68-76
    CrossrefPubMedGoogle Scholar
  • 40 Sillberg VA, Wells GA, Perry JJ. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: A meta-analysis. Stroke 2008; 39: 2622-6
    CrossrefPubMedGoogle Scholar
  • 41 Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2005; 1 DOI: CD000277.
    CrossrefPubMedGoogle Scholar
  • 42 Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M. et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007; 18 DOI: CD000277.
    CrossrefPubMedGoogle Scholar
  • 43 Roos YB, Levi M, Carroll TA, Beenen LF, Vermeulen M. Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 2001; 32: 1860-2
    CrossrefPubMedGoogle Scholar
  • 44 Jun P, Ko NU, English JD, Dowd CF, Halbach VV, Higashida RT. et al. Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2010; 31: 1911-6
    CrossrefPubMedGoogle Scholar
  • 45 Shankar JJ, dos Santos MP, Deus-Silva L, Lum C. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage. Neuroradiology 2011; 53: 123-8
    CrossrefPubMedGoogle Scholar
  • 46 Smith WS, Dowd CF, Johnston SC, Ko NU, DeArmond SJ, Dillon WP. et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2004; 35: 2518-22
    CrossrefPubMedGoogle Scholar
  • 47 Terry A, Zipfel G, Milner E, Cross 3rd DT, Moran CJ, Diringer MN. et al. Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurg Focus 2006; 21: E14
    PubMedGoogle Scholar
  • 48 Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N. et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006; 34: 617-23
    CrossrefPubMedGoogle Scholar
  • 49 Manninen PH, Ayra B, Gelb AW, Pelz D. Association between electrocardiographic abnormalities and intracranial blood in patients following acute subarachnoid hemorrhage. J Neurosurg Anesthesiol 1995; 7: 12-6
    CrossrefPubMedGoogle Scholar
  • 50 Szabo MD, Crosby G, Hurford WE, Strauss HW. Myocardial perfusion following acute subarachnoid hemorrhage in patients with an abnormal electrocardiogram. Anesth Analg 1993; 76: 253-8
    CrossrefPubMedGoogle Scholar
  • 51 Hravnak M, Frangiskakis JM, Crago EA, Chang Y, Tanabe M, Gorcsan 3rd J. et al. Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. Stroke 2009; 40: 3478-84
    CrossrefPubMedGoogle Scholar
  • 52 Mayer SA, LiMandri G, Sherman D, Lennihan L, Fink ME, Solomon RA. et al. Electrocardiographic markers of abnormal left ventricular wall motion in acute subarachnoid hemorrhage. J Neurosurg 1995; 83: 889-96
    CrossrefPubMedGoogle Scholar
  • 53 Deininger MH, Radicke D, Buttler J, Scheufler KM, Freiman T, Zentner JF. Tako-tsubo cardiomyopathy: Reversible heart failure with favorable outcome in patients with intracerebral hemorrhage. Case report. J Neurosurg 2006; 105: 465-7
    CrossrefPubMedGoogle Scholar
  • 54 Jain R, Deveikis J, Thompson BG. Management of patients with stunned myocardium associated with subarachnoid hemorrhage. AJNR Am J Neuroradiol 2004; 25: 126-9
    PubMedGoogle Scholar
  • 55 Gruber A, Reinprecht A, Görzer H, Fridrich P, Czech T, Illievich UM. et al. Pulmonary function and radiographic abnormalities related to neurological outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 1998; 88: 28-37
    CrossrefPubMedGoogle Scholar
  • 56 Gruber A, Reinprecht A, Illievich UM, Fitzgerald R, Dietrich W, Czech T. et al. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med 1999; 27: 505-14
    CrossrefPubMedGoogle Scholar
  • 57 Kahn JM, Caldwell EC, Deem S, Newell DW, Heckbert SR, Rubenfeld GD. Acute lung injury in patients with subarachnoid hemorrhage: Incidence, risk factors, and outcome. Crit Care Med 2006; 34: 196-202
    CrossrefPubMedGoogle Scholar
  • 58 Rosenberg NF, Koht A, Naidech AM. Anemia and transfusion after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2013; 25: 66-74
    CrossrefPubMedGoogle Scholar
  • 59 Oliveira-Filho J, Ezzeddine MA, Segal AZ, Buonanno FS, Chang Y, Ogilvy CS. et al. Fever in subarachnoid hemorrhage: Relationship to vasospasm and outcome. Neurology 2001; 56: 1299-304
    CrossrefPubMedGoogle Scholar
  • 60 Douds GL, Tadzong B, Agarwal AD, Krishnamurthy S, Lehman EB, Cockroft KM. Influence of fever and hospital-acquired infection on the incidence of delayed neurological deficit and poor outcome after aneurysmal subarachnoid hemorrhage. Neurol Res Int 2012; 2012: 6
    PubMedGoogle Scholar
  • 61 Badjatia N, Fernandez L, Schmidt JM, Lee K, Claassen J, Connolly ES. et al. Impact of induced normothermia on outcome after subarachnoid hemorrhage: A case-control study. Neurosurgery 2010; 66: 696-700
    CrossrefPubMedGoogle Scholar
  • 62 Harrigan MR. Cerebral salt wasting syndrome: A review. Neurosurgery 1996; 38: 152-60
    CrossrefPubMedGoogle Scholar
  • 63 Qureshi AI, Suri MF, Sung GY, Straw RN, Yahia AM, Saad M. et al. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2002; 50: 749-55
    CrossrefPubMedGoogle Scholar
  • 64 Berendes E, Walter M, Cullen P, Prien T, Van Aken H, Horsthemke J. et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997; 349: 245-9
    CrossrefPubMedGoogle Scholar
  • 65 Sherlock M, O'Sullivan E, Agha A, Behan LA, Rawluk D, Brennan P. et al. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf) 2006; 64: 250-4
    CrossrefPubMedGoogle Scholar
  • 66 Cowley Jr. AW, Roman RJ. Control of blood and extracellular volume. Baillieres Clin Endocrinol Metab 1989; 3: 331-69
    CrossrefPubMedGoogle Scholar
  • 67 Nagano A, Yamada Y, Miyake H, Domen K, Koyama T. Increased resting energy expenditure after endovascular coiling for subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 2016; 25: 813-8
    CrossrefPubMedGoogle Scholar
  • 68 Kasuya H, Kawashima A, Namiki K, Shimizu T, Takakura K. Metabolic profiles of patients with subarachnoid hemorrhage treated by early surgery. Neurosurgery 1998; 42: 1268-74
    CrossrefPubMedGoogle Scholar
  • 69 Badjatia N, Monahan A, Carpenter A, Zimmerman J, Schmidt JM, Claassen J. et al. Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage. Neurology 2015; 84: 680-7
    CrossrefPubMedGoogle Scholar
  • 70 Suarez JI, Zaidat OO, Suri MF, Feen ES, Lynch G, Hickman J. et al. Length of stay and mortality in neurocritically ill patients: Impact of a specialized neurocritical care team. Crit Care Med 2004; 32: 2311-7
    CrossrefPubMedGoogle Scholar
  • 71 Varelas PN, Conti MM, Spanaki MV, Potts E, Bradford D, Sunstrom C. et al. The impact of a neurointensivist-led team on a semiclosed neurosciences intensive care unit. Crit Care Med 2004; 32: 2191-8
    CrossrefPubMedGoogle Scholar
  • 72 Samuels O, Webb A, Culler S, Martin K, Barrow D. Impact of a dedicated neurocritical care team in treating patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011; 14: 334-40
    CrossrefPubMedGoogle Scholar